DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER

Application of dabigatran etexilate for prevention of cardioembolic complications in nonvalvular atrial fibrillation is considered. Results of randomized clinical trials on efficacy and safety of dabigatran in various doses are discussed. Besides, a comparison of dabigatran and varfarin therapies is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: I. S. Yavelov
Formato: Artigo
Idioma:Inglês
Publicado em: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Colecção:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Assuntos:
atrial fibrillation
dabigatran
randomized clinical trials
Acesso em linha:https://www.rpcardio.com/jour/article/view/991
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados